Lv4
670 积分 2022-12-01 加入
Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial
16小时前
已完结
Relapsing Whipple’s disease in patients with severe arthritis
6天前
已完结
Whipple's disease and Tropheryma whipplei infections: from bench to bedside
7天前
已完结
靶向TROP2的抗体药物偶联物应用于非小细胞肺癌的专家共识（2026版）
1个月前
已完结
The spectroscopy of flames
1个月前
已关闭
Tropheryma whipplei pneumonia revealed by Metagenomic next-generation sequencing: Report of two cases
2个月前
已完结
Tropheryma whipplei pneumonia revealed by Metagenomic next-generation sequencing: Report of two cases
2个月前
已完结
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
3个月前
已完结
Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer
4个月前
已完结
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
4个月前
已完结
皖公网安备34019202002308
